跳到正文
European Pharmaceutical Review·AI 评分56

暴露速率影响制药冻融循环中的微生物存活风险

Exposure rate influences microbial viability risk during pharmaceutical freeze-thaw cycling

AI 导读

AstraZeneca 科学家的研究显示,反复冻融循环对微生物存活力的损伤通常大于单次冻融,但结果因微生物种类和基质而异。研究将八种微生物悬浮于胰蛋白酶大豆肉汤(TSB)、纯化水和磷酸盐缓冲液(PBS)中于 -20°C 保存,经单次四周冻融或四周内每周反复冻融后,用膜过滤和菌落计数评估存活,革兰阴性菌对冻融和单次冻融更敏感。作者认为冻融暴露减少但未必消除微生物存活,论文发表于 EJPPS。

正文 · 原文

Research supports pharmaceutical microbiological risk assessments and thaw-handling steps during manufacture and storage.

frozen-samples-hands-scientist

Repeated freeze-thaw cycling is generally more damaging to microorganisms than a single thaw during pharmaceutical development and manufacture, research by AstraZeneca scientists suggest.

Walker et al. concluded that “freeze-thaw exposure reduces, but does not necessarily eliminate, microbial survival.”

The finding is notable, says Walker et al. While frozen storage for pharmaceutical preparations is common, “the microbiological consequences of thaw-handling remain insufficiently identified, resulting in uncertainty and inconsistency in microbial risk assessment”.

freeze-thaw exposure reduces, but does not necessarily eliminate, microbial survival”

For example, the authors highlighted that thawing of solutions and suspensions “may involve repeated freeze-thaw cycles and ambient handling windows, creating opportunities for contamination events to influence microbial proliferation”.

In their study, eight microorganisms were suspended in tryptone soya broth (TSB), purified water (PW), and phosphate-buffered saline (PBS) and stored at -20°C. Their viability was assessed following either a single freeze-thaw event after four weeks or repeated weekly freeze-thaw cycling over four weeks using membrane filtration and colony enumeration.

The authors expected repeated cycling to “bring greater loss of cultivability than a single thaw, and that survival would be highest in TSB and lowest in purified water”.

Yet results showed the repeated protocol “generally caused greater viability loss than a single freeze-thaw event, although responses varied by organism and matrix”.

Despite no microbial proliferation being observed during thawing, “Gram-negative organisms were more susceptible to the effects of freeze/thaw and single thaw”.

Walker et al. theorised that including product formulations would improve applicability of the results directly to early-stage drug development and manufacturing environments.

Overall, the study provides evidence to justify freeze-thaw stages of microorganisms during pharmaceutical manufacture and storage.

The paper was published in EJPPS.

来源:European Pharmaceutical Review · europeanpharmaceuticalreview.com